MATERIAL AND METHODS Patients

A reduced response to interferon therapy has been described in individuals with chronic hepatitis C and serological markers of a resolved HBV infection (HBsAg

Background and aim: The durability of the sustained virologic response (SVR) in patients with chronic hepatitis C after treatment and the ideal follow-up time for

The association between viral load, and SVR with the development of thyroid disorders was not part of this study protocol, considering that our prima- ry objective was the

Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. Evaluation and comparison of different

Serum aminotransferases testing has been widely used as a marker of liver disease activity, however, the literature has objected to this finding, because liver biopsies carried out

Polymorphism of tumor necrosis factor-α and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated interferon-α therapy

The role autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon alpha and ribavirin combination

Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.. Resposta terapêutica ao interferon beta e ao acetato de glatiramer